San Diego-based NuVasive, Inc. has announced the expansion of its San Diego global headquarters and creation of an innovation center of excellence.
NuVasive Expands, Adding Innovation Center of Excellence

Surgeons from around the globe will be able to visit the center to train on the latest NuVasive spine technology and procedures.
As the company wrote in its August 29, 2017 news release, “NuVasive’s San Diego campus, located at 7475 Lusk Boulevard in Sorrento Valley, will increase by more than 100,000 square feet, bringing the total space to approximately 250,000 square feet.”
“Expansion plans include renovating the current two buildings on campus and adding a third building. The newly renovated campus will include an innovation center of excellence, showcasing the Company’s state-of-the-art product and procedural offerings and highlighting its world renowned surgeon education.”
“Additional features of the campus include: an expanded surgeon education lab for onsite surgeon training and education; a prototype design facility with 3D printing capabilities; state-of-the-art biomedical testing center; and a new amenities building which will include an onsite café, fitness center and meeting space to accommodate up to 750 attendees.”
“Our headquarters expansion reflects our commitment to the San Diego region where medical technology companies and the life sciences industry have significantly contributed to the growth for decades,” said Gregory T. Lucier, NuVasive’s chairman and chief executive officer.
“Our new facility will offer NuVasive the unique opportunity to have our design facility, lab space and product development in one location where visiting surgeons and our product development teams can collaborate closely on our newest technologies. With the support of Mayor Faulconer and the San Diego Regional Chamber of Commerce, we are eager to continue our investment into the San Diego area with a facility that attracts, retains and grows the high-performing employee talent we have here at NuVasive.”
“It’s an exciting day for NuVasive and a proud moment for San Diego,” said San Diego Mayor Kevin Faulconer. “NuVasive is a homegrown company that’s supporting our innovation economy, creating jobs for San Diegans and leading the world in transformative spinal surgeries. We will continue to create an environment in San Diego where companies like NuVasive can grow and thrive.”
Gregory Lucier told OTW, “We worked closely with city, county and state officials on our plans to expand. Getting their support was crucial in our decision to stay in San Diego and expand.”
“As part of our on-going commitment to providing surgeon education, we invite surgeons here who are interested in being trained on our procedures. We are committed to developing products and procedures that help drive better clinical and economic outcomes. As a result, these procedures are new and many surgeons will not have trained on them during medical school. They can visit our labs and operating room to learn these procedures. We have a full program that includes proctors teaching these courses and we provide an opportunity to have hand’s on learning experience in our state of the art labs and using our technology.”

Discussion
This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?
Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.
We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.
Join the conversation
Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.